BackAryx Therapeutics Overview

Aryx Therapeutics Current Assets

Latest current assets for ARYX: $3.7M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$3.68M
75.62% YoYΔ $-11.42M vs prior year quarter

Peer average

Loading

Aryx Therapeutics Current Assets History

Loading

Aryx Therapeutics vs. peers: Current Assets Comparison

Loading

Aryx Therapeutics Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Aryx Therapeutics (ARYX) FAQ

As of the most recent data (September 2010), ARYX shows a current assets of $3.7M. That compares with $15M in the prior-year period — down 75.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ARYX's current assets is now $3.7M (was $15M) — a 75.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Aryx Therapeutics is outperforming or lagging.

Tracking ARYX's current assets over time shows whether Aryx Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $3.7M That compares with $15M in the prior-year period — down 75.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Aryx Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $3.7M) with ownership activity and broader fundamentals.

Aryx Therapeutics's current assets is $3.7M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.